MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Utilization and longitudinal impact of anticholinergic use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry

    V. Felix Saunders, K. Li, S. Luo, T. Simuni (Chicago, IL, USA)

    Objective: To evaluate baseline predictors and longitudinal impact of anticholinergics use in Parkinson's disease (PD). Background: Anticholinergics have beneficial effect on tremor in PD but…
  • 2016 International Congress

    Experience with utilization of rytary in the clinical setting

    Y. Kianirad, T. Simuni, C. Zadikoff, D. Bega, M. Afshari, S. Jonnalagadda (Chicago, IL, USA)

    Objective: To explore the utilization and tolerability of Rytary in the clinical setting. Background: Rytary is a novel extended-release carbidopa-levodopa (CD-LD) formulation that was approved…
  • 2016 International Congress

    Improvement of freezing of gait with intestinal levodopa infusion in advanced Parkinson’s disease patients

    M. Zibetti, S. Angrisano, F. Dematteis, A. Romagnolo, A. Merola, L. Lopiano (Torino, Italy)

    Objective: To determine whether levodopa-carbidopa intestinal gel (LCIG) infusion is able to improve freezing of gait (FOG) in advanced Parkinson's disease (PD) patients. Background: FOG…
  • 2016 International Congress

    Dopamine dysregulation syndrome /DDS/ in LCIG infusion: Successful treatment without interrupting the pump therapy

    A. Tóth, H. Nagy, S. Funk, A. Takáts (Budapest, Hungary)

    Objective: Here we report the case of a 49-year-old man with a 19 years history of PD presenting DDS while he was on LCIG therapy.…
  • 2016 International Congress

    Safety and efficacy of pardoprunox for patients with Parkinson’s disease: A meta-analysis

    N. Elsagheer, H. Ahmed, A. Attia, K. Awad, E. Ezzat, M. Abd Elaleem Aziz, A. Negida (Beni Suef, Egypt)

    Objective: The aim of this meta-analysis is to synthesize evidence from published randomized controlled trials (RCTs) about the safety and efficacy of Pardoprunox for Patients…
  • 2016 International Congress

    Objective measurement in clinical care of patients with Parkinson’s disease

    M. Horne, K. Kotschet, M. Braybrook (Parkville, Australia)

    Objective: To establish whether using the Parkinson's KinetiGraph™ which provides objective measures in activities of daily living, helps identify unknown poorly controlled patients with Parkinson's…
  • 2016 International Congress

    The efficacy of tremor detection and suppression device in intractable rest tremor in patients with Parkinson’s disease

    O. Jitkritsadakul, C. Thanawattano, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: This study was designed to determine the efficacy of the Tremor Detection and Suppression device (TDS) as a therapeutic option in PD patients with…
  • 2016 International Congress

    A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Signal of efficacy

    M.R. Landers, J.W. Navalta (Las Vegas, NV, USA)

    Objective: To determine if a high intensity exercise and fall prevention boot camp (HIBC) would produce greater benefit than a low intensity control (Fitness Counts…
  • 2016 International Congress

    Best supportive care or palliative care for late stage Parkinsonian syndromes?

    S. Lorenzl, C. Richinger, C. Schmotz, G. Nübling (Salzburg, Austria)

    Objective: To ask whether best supportive care might be more suitable for patients with Parkinson's disease (PD) and Parkinsonian syndromes and their family than palliative…
  • 2016 International Congress

    Hospitalisation following different initial therapies in early Parkinson’s disease: Analysis of hospital episodes statistics from the PD MED EARLY trial

    S. Muzerengi, R.L. Woolley, C. Rick, N. Ives, F. Dowling, R. Gray, C.E. Clarke, PD MED Collaborative Group (Birmingham, United Kingdom)

    Objective: To compare hospitalisation rates of Parkinson's disease (PD) patients randomised between three different classes of oral medications used for early PD treatment. Background: PD…
  • « Previous Page
  • 1
  • …
  • 1923
  • 1924
  • 1925
  • 1926
  • 1927
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley